Product Information
DICYCLOMINE 20 MG TABLET is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.0590 per EA under NDC 24979020003. Its NADAC has been published 163 times since Aug 23, 2023.
FDA first approved this application on Jun 1, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
24979020003
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DICYCLOMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216782FDA Approved
6/1/2023
TE Code
AB
On Market Since
7/1/2023
Pharmacological Classes
Price Statistics
The NADAC for DICYCLOMINE 20 MG TABLET has been published 163 times since Aug 23, 2023, and over the history we have for it it has declined 57.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0590 per EA |
|---|---|
| All-time high | $0.1448 (Jan 10, 2024) |
| All-time low | $0.0555 (Apr 22, 2026) |
| 52-week high | $0.0674 |
| 52-week low | $0.0555 |
| Median price | $0.0835 |
| Average price | $0.0882 |
| Largest weekly change | +33.0% (Aug 21, 2024) |
| Weeks tracked | 163 |
| Tracking since | Aug 23, 2023 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dicyclomine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DICYCLOMINE 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DICYCLOMINE 20 MG TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.0590 per EA (NDC 24979020003), effective Sep 30, 2026.
How has the price of DICYCLOMINE 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for DICYCLOMINE 20 MG TABLET has declined 57.5%. It has been tracked across 163 weekly CMS publications since Aug 23, 2023.
What are the highest and lowest recorded NADAC prices for DICYCLOMINE 20 MG TABLET?
Since Aug 23, 2023, the NADAC for DICYCLOMINE 20 MG TABLET has ranged from a low of $0.0555 (Apr 22, 2026) to a high of $0.1448 (Jan 10, 2024), with a median of $0.0835 per EA.
Are there cheaper alternatives to DICYCLOMINE 20 MG TABLET?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DICYCLOMINE 20 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DICYCLOMINE 20 MG TABLET?
DICYCLOMINE 20 MG TABLET (NDC 24979020003) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.